Revenue segments as reported by the company.

Clearing and transaction fees

Market data and information services

Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Compensation and benefits  

Technology

Professional fees and outside services

Amortization of purchased intangibles

Depreciation and amortization

Licensing and other fee agreements

Other expenses

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CME Group

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CME Group achieves record-breaking 2022 performance amidst market challenges

CME Group's 2022 performance was exceptional, marked by record volumes, revenue growth, and successful transitions. The company's focus on innovation, strategic positioning in energy and cryptocurrency markets, and pricing adjustments have driven positive outcomes. Challenges in margins and market uncertainties require careful navigation.

CME Group posts record Q1 earnings, eyes growth in SOFR

CME Group delivered a strong performance in Q1 2023, achieving record revenue and profitability driven by growth in interest rate and options trading.
The company's strategic focus on risk management, shareholder value creation, and market competitiveness positions it well for future growth and revenue generation.
While facing challenges in a competitive market environment, CME Group has opportunities to capitalize on the demand for SOFR products and options trading.
Optimism surrounding the company's future growth potential, coupled with effective expense management and revenue diversification, underpin its resilience and strategic outlook.

CME Group excels in Q2 with record revenue and strategic focus

CME Group's Q2 earnings call showcased strong financial performance, driven by growth across asset classes and a focus on customer-centric strategies. The company's emphasis on innovation, regulatory compliance, and market leadership positions it well for future growth.

CME Group reports strong Q3 earnings, eyes growth amid challenges

CME Group's Q3 2023 earnings call highlighted robust financial performance, operational efficiency, and strategic positioning. Despite facing regulatory challenges and cost management concerns, the company remains confident in its offerings and growth prospects. Opportunities for expansion through innovation and capitalizing on market trends were key discussion points.

CME Group achieves record 2023 results amidst global uncertainties

CME Group's record-breaking performance in 2023 underscores its market leadership and financial strength, with revenue growth, margin expansion, and strong product demand driving positive results.
While facing challenges from global uncertainties and market dynamics, the company's strategic focus on innovation, risk management, and efficiency positions it well to capitalize on opportunities in evolving markets.
By introducing new products, expanding partnerships, and navigating changing market conditions adeptly, CME Group demonstrates resilience and adaptability, paving the way for continued growth and success in the financial industry.
Overall, CME Group's strategic initiatives, financial performance, and market positioning reflect a company poised for sustained success, leveraging opportunities and strengths to overcome challenges and drive future growth.

CME Group achieves record earnings in Q1 2024, eyes growth

CME Group delivered a strong performance in Q1 2024, setting records in revenue and earnings.
The company faces challenges in managing expenses amid growth initiatives and competitive dynamics.
However, CME's strengths in market leadership, network infrastructure, and regulatory alignment position it well for future opportunities.
By capitalizing on data services and revenue growth avenues, CME can continue its upward trajectory in the market.

CME Group achieves record Q3 performance amidst regulatory challenges

CME Group's Q3 performance was exceptional, marked by record volumes and financial metrics. Despite challenges in regulatory compliance and competition, the company is well-positioned for growth through strategic opportunities in interest rate products and retail expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Low volatility in several asset classes created revenue headwinds for CME Group in the second half of 2020. The outlook for a return to growth in trading volumes is likely as the "global reflation trade" could have further to run.

CME Group Should Benefit From The Global Reflation Trade

CHICAGO, March 3, 2021 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, today announced that its Global Emissions Offset (GEO) futures have launched and are available for trading. The total volume for the first two trading days was 81 contracts...

CME Group Announces First Trades of Global Emissions Offset (GEO) Futures

CME Group's (CME) average daily volume of 24.6 million contracts per day declines 18% year over year, due to lower volumes in all the six product lines.

CME Group (CME) February Volumes Decline Year Over Year

CHICAGO, March 2, 2021 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, today reported February 2021 market statistics, including average daily volume (ADV) of 24.6 million contracts during the month. Market statistics are available in greater...

CME Group Reports February 2021 Monthly Market Statistics

CHICAGO, Feb. 26, 2021 /PRNewswire/ -- CME Group announced today that John Pietrowicz, Chief Financial Officer; Julie Winkler, Chief Commercial Officer; and Derek Sammann, Global Head of Commodities and Options Products; will present virtually at the 42nd Annual Raymond James Virtual...

CME Group Chief Financial Officer, Chief Commercial Officer and Global Head of Commodities and Options Products to Present at Raymond James Virtual Institutional Investors Conference

CHICAGO, Feb. 26, 2021 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, today announced that Secured Overnight Financing Rate (SOFR) futures reached a daily volume record of 265,511 contracts on February 25, surpassing the previous record of 240,288...

CME Group Announces Record SOFR Futures Trading Volume and Open Interest on February 25

CHICAGO, Feb. 25, 2021 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, today announced that Ultra 10-Year Note futures reached a record volume of 1.7 million contracts on February 23, surpassing the previous record of 1.5 million set on February...

CME Group Announces Record Ultra 10-Year Note and 30-Year Bond Futures Volumes on February 23

Expedia

Mattel

AT&T

Urban Outfitters

Canadian Pacific Kansas City Limited

Global Blood Therapeutics

NetApp

SAGE Therapeutics

With the trading day more than halfway over, the broad markets saw a huge pull back on Thursday.

AT&T, Expedia, Mattel, Urban Outfitters and More Thursday Afternoon Analyst Calls

CHICAGO, Feb. 22, 2021 /PRNewswire/ -- CME Group announced today that John Pietrowicz, Chief Financial Officer and Sean Tully, Global Head of Financial and OTC Products, will present virtually at the 22nd Annual Credit Suisse Virtual Financial Services Forum on Thursday, Feb. 25, 2021, at...

CME Group Chief Financial Officer and Global Head of Financial and OTC Products to Present at Credit Suisse Virtual Financial Services Forum

Why CME Group Needs to See Increased Bond Market Volatility

CME Group Inc. (CME) CEO Terry Duffy on Q4 2020 Results - Earnings Call Transcript

CME Group (CME) Q4 results reflect strong, double-digit, year-over-year growth in the fourth quarter across its Equity Index and Agricultural businesses.

CME Group (CME) Q4 Earnings and Revenues Beat Estimates

CME (CME) delivered earnings and revenue surprises of 2.96% and 0.32%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

CME Group (CME) Surpasses Q4 Earnings and Revenue Estimates

CME Group is scheduled to report its fiscal Q4 2020 results on Wednesday, February 10. We expect CME Group to likely beat the consensus estimates for revenues and earnings.

CME Group Stock Is Likely To Beat Consensus In Q4

CME Group's (CME) fourth-quarter performance is likely to have benefited from higher fixed income volume and foreign exchange volume and lower expenses.

What's in Store for CME Group (CME) This Earnings Season?

CHICAGO, Feb. 8, 2021 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, today launched Ether futures, further expanding its crypto derivatives offerings in this emerging asset class. "As institutional demand for transparent, exchange-listed crypto...

CME Group Announces Launch of Ether Futures

The move follows a banner 2020 for the financial markets operator.

CME Group Declares 6% Dividend Raise

CME (CME) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: CME Group (CME) Q4 Earnings Expected to Decline

CHICAGO, Feb. 2, 2021 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, today reported January 2021 market statistics, including average daily volume (ADV) of 19.2 million contracts during the month. Market statistics are available in greater detail...

CME Group Reports January 2021 Monthly Market Statistics

The largest derivatives market is expanding in cryptocurrencies, with big repercussions for digital money.

What's the Best Cryptocurrency Stock? It Might Be CME Group

Mastercard

Dividends from blockchain and cryptocurrency stocks can provide passive income. Learn what these dividends are and stocks to consider investing in.

Best Blockchain and Cryptocurrency Stocks for Dividends

LONDON and SINGAPORE, Jan. 19, 2021 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, today announced that it achieved record international average daily volume (ADV) of 5.2 million contracts in 2020, up 8 percent from 2019. This record, reflecting...

CME Group Achieves Record International Average Daily Volume of 5.2 Million Contracts in 2020, Up 8 Percent from 2019

LONDON and NEW YORK, Jan. 18, 2021 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, today announced that BrokerTec, a leading provider of electronic trading platforms and technology services in fixed income markets, has successfully migrated its...

CME Group Completes Migration of BrokerTec EU Government Bond and EU Repo Trading Platform to CME Globex

Foot Locker

PayPal

Tesla

YETI

Aphria

AstraZeneca

3D Systems

Monster Beverage

Signet Jewelers

With the trading day about half over, the broad markets were pulling back on Friday afternoon.

AstaZeneca, Foot Locker, PayPal, Tesla, Yeti and More of Friday Afternoon's Analyst Calls

Harbor PanAgora Dynamic Large Cap Core ETF

CME Group (CME) and IHS Markit combine their post-trade services to boost the OTC markets.

News for CME Group Stock (CME)